Probiotics for chemoradiotherapy-induced oral mucositis

New research suggests that in patients with nasopharyngeal carcinoma, severity of oral mucositis—a common complication of chemoradiotherapy—might be decreased by giving patients a probiotic combination, which augments the patients' immune response and modifies the intestinal microbiota.